Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
28.550
-2.450
(-7.90%)
As of 2:21:07 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-233,781
-200,944
-220,053
Investing Cash Flow
-71,538
73,008
-158,165
Financing Cash Flow
287,707
223,997
351,139
End Cash Position
45,199
186,830
90,762
Capital Expenditure
-44,522
-77,254
-88,174
Issuance of Capital Stock
235,000
185,000
325,000
Free Cash Flow
-278,303
-278,198
-308,227
12/31/2022 - 8/20/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2105.HK Laekna, Inc.
11.800
-6.79%
2171.HK CARsgen Therapeutics Holdings Limited
12.860
+0.47%
2563.HK Beijing Biostar Pharms Co Ltd
17.900
+1.24%
2566.HK Hangzhou Jiuyuan Gene
7.090
-0.98%
2142.HK HBM Holdings Limited
5.320
-2.92%
1952.HK Everest Medicines Limited
44.050
-2.33%
1548.HK GENSCRIPT BIO
13.380
+1.21%
1873.HK VIVA BIOTECH
1.430
-10.06%
1672.HK ASCLETIS-B
5.680
-5.80%
AXSM Axsome Therapeutics, Inc.
137.75
+6.70%